Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1537182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Wei-Chao Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, Doxycycline, Mycoplasma pneumoniae, Macrolides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Commensal bacterial community along the upper respiratory tract functions against pathogens. The host determinants of Mycoplasma pneumoniae severity should be identified against the increasing threat of macrolide-resistant M. pneumoniae (MRMP) infection. We hypothesized that respiratory microbiome is involved in the clinical manifestations of M. pneumoniae infection.
Methods
From 2017 to 2020, 92 children with MRMP-mediated pneumonia were enrolled among 845 children with community-associated pneumonia. Oropharyngeal samplings were collected within 48 h after admission. We compared respiratory microbiome and metabolites based on patients’ later development of prolonged fever and the need for doxycycline treatment (DT, n = 57) and the cured control without fever or doxycycline treatment (WDT, n = 35) by using 16S rRNA-based sequencing and untargeted metabolome analysis.
Results
Significantly higher diversity and different respiratory microbiomes were evaluated in WDT patients in contrast to DT patients. Fusobacterium , Haemophilus , Gemella , Oribacterium , Actinomyces lingnae , Fusobacterium periodonticum , Gemella sanguinis , and Solobacterium moorei were inversely correlated with disease severity. We assumed that metabolites of divergent microbiomes were related to MRMP development. We identified 15 discriminative amino-acid- and fatty-acid-related metabolites in two groups. F. periodonticum abundance was negatively associated with an inflammatory metabolite: a platelet-activating factor. Fusobacterium and Oribacterium were related to the decrease in LysoPE(18:1(9Z)/0:0) and LysoPC(18:1(9Z)).
Conclusions
Microbiota dysbiosis with dysregulated inflammatory glycerolphospholipid-related metabolites was related to disease severity and the need for doxycycline treatment in children with MRMP-mediated pneumonia. Anaerobic bacteria metabolites and metabolic pathway could be beneficial therapeutic targets against M. pneumoniae infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
- Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
- Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Taiwan.
- Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Institute of BioMedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Zitieren
APA
Liao, W. C., Li, S. W., Hsing, E. W., Hsiao, S. H., Chang, I. Y., Chen, Y. C., Chen, Y. Y., Pan, Y. J., & Hsieh, Y. C. (2025). Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1537182
Vancouver
Liao WC, Li SW, Hsing EW, Hsiao SH, Chang IY, Chen YC, et al. Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1537182
BibTeX
@article{Liao2025,
author = {Liao, Wei-Chao and Li, Shiao-Wen and Hsing, En-Wei and Hsiao, Sung-Han and Chang, Ian Yi-Feng and Chen, Yin-Cheng and Chen, Yi-Yin and Pan, Yi-Jiun and Hsieh, Yu-Chia},
title = {Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1537182}
}
EUVIMED